gfa-918
Small moleculeexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 13, 2014 (NCT05295134)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
GPR160 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04754373 | Phase 2 | Jul 13, 2018 | BIO-CAT Microbials, LLC, KGK Science Inc. |
| NCT05295134 | N/A | Mar 13, 2014 | Atlantia Food Clinical Trials, BIO-CAT Inc., National University of Ireland |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Atlantia Food Clinical Trials | For profit | 1 | 0 | 1 | 2014 |
| BIO-CAT Inc. | For profit | 1 | 1 | 1 | 2014 |
| BIO-CAT Microbials, LLC | For profit | 1 | 1 | 1 | 2018 |
| KGK Science Inc. | For profit | 1 | 0 | 1 | 2018 |
| National University of Ireland | Academic/Hospital | 1 | 0 | 1 | 2014 |
5 organizations
Page 1 / 1